高等学校化学学报 ›› 2014, Vol. 35 ›› Issue (12): 2584.doi: 10.7503/cjcu20140333

• 有机化学 • 上一篇    下一篇

吡啶联异噁唑类化合物的设计、 合成及抗肿瘤活性

杨洪亮1, 徐国兴1, 宝梅英2, 张大鹏1, 李志伟1(), 裴亚中1()   

  1. 1. 吉林大学药学院, 组合化学与创新药物研究中心, 长春 130021
    2. 长春吉大天元化学技术股份有限公司, 长春 130012
  • 收稿日期:2014-04-09 出版日期:2014-12-10 发布日期:2014-11-06
  • 作者简介:联系人简介: 裴亚中, 男, 博士, 教授, 博士生导师, 主要从事多样化合成与创新药物研究. E-mail:peiyz@jlu.edu.cn;李志伟, 男, 博士, 教授, 博士生导师, 主要从事生物和药物筛选研究. E-mail:zwl.jida@gmail.com
  • 基金资助:
    国家自然科学基金(批准号: 81172914, 81071743)、 吉林大学唐敖庆教授启动资金和吉林省人才开发基金(批准号: 802110000432)资助

Design and Synthesis of Pyridinylisoxazoles and Their Anticancer Activities

YANG Hongliang1, XU Guoxing1, BAO Meiying2, ZHANG Dapeng1, LI Zhiwei1,*(), PEI Yazhong1,*()   

  1. 1. The Center for Combinatorial Chemistry and Drug Discovery, School of Pharmaceutical Sciences,Jilin University, Changchun 130021, China
    2. Changchun Discovery Sciences Co. Ltd., Changchun 130012, China
  • Received:2014-04-09 Online:2014-12-10 Published:2014-11-06
  • Contact: LI Zhiwei,PEI Yazhong E-mail:zwl.jida@gmail.com;peiyz@jlu.edu.cn
  • Supported by:
    † Supported by the National Natural Science Foundation of China(Nos.81172914, 81071743), the Tang Aoqing Professorship Research Grant from Jilin University, China and Jilin Province Talent Development Program, China(No.802110000432)

摘要:

根据已知的激酶变构抑制剂与其靶点激酶的X射线共晶结构, 设计了一系列以吡啶联异噁唑为中心结构的潜在激酶变构抑制剂. 以2-甲基-5-硝基-3-吡啶甲酸甲酯为原料, 通过形成酰胺、 磺酰胺和连接嘧啶片段等衍生化手段合成了21个新的吡啶联异噁唑类化合物, 其结构经1H NMR, 13C NMR和MS确证. 采用噻唑蓝(MTT)法测试了所合成化合物的体外抗肿瘤活性, 初步测试结果表明该类化合物对肿瘤细胞的增长具有显著的抑制作用.

关键词: 吡啶联异噁唑, 蛋白激酶, 变构抑制剂, 抗肿瘤活性

Abstract:

Based on the X-ray co-crystal structures of reported allosteric kinase inhibitors bound to their corresponding protein kinases, a pharmacophore model was proposed. To examine the validity of this hypothesis, 21 new pyridinylisoxazole derivatives were designed and synthesized. Their structures were confirmed using 1H NMR, 13C NMR and MS data. Their inhibitory effects against human breast cancer cell(MCF-7) proliferation were evaluated. Preliminary results indicated that some of these pyridinylisoxazole derivatives possess potent anti-proliferative activities, with IC50 data in the micromolar range. The mechanism-of-action of these compounds is under investigation.

Key words: Pyridinylisoxazole, Protein kinase, Allosteric kinase inhibitor, Antitumor activity

中图分类号: 

TrendMD: